Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 18/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.72 |
| ▸ | MME | P08473 | 2/20 | 0.61 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15637179 | 0.92 | CTSA (0.70) | CTSACYP3A4MME | |
| SCHEMBL15637640 | 0.91 | CTSA (0.81) | CTSACYP3A4MMEPTGS2 | |
| SCHEMBL15636818 | 0.91 | CTSA (0.77) | CTSACYP3A4MMEPTGS2 | |
| SCHEMBL15636092 | 0.90 | CTSA (0.57) | CTSACYP3A4MMEEGLN2EGLN1 | |
| SCHEMBL15635745 | 0.90 | CTSA (0.79) | CTSACYP3A4MME | |
| SCHEMBL15636911 | 0.89 | CTSA (0.75) | CTSACYP3A4MMEPTGS2 | |
| SCHEMBL15636993 | 0.87 | CTSA (0.73) | CTSACYP3A4MMEPTGS2 | |
| SCHEMBL15636125 | 0.87 | CTSA (0.53) | CTSACYP3A4MMEEGLN2EGLN1 | |
| SCHEMBL15635907 | 0.86 | CTSA (0.88) | CTSACYP3A4MME | |
| SCHEMBL15636894 | 0.85 | CTSA (0.74) | CTSACYP3A4MMEPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014053533-A1 | USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION | SANOFI (FR) | 2014-04-10 | — | — | WO | disclosed |